Envol Biomedical at ACT 2026

Nov 15–18, 2026 San Antonio, TX ~1.4k attendees Website

Envol Biomedical takes part in 1 session at ACT 2026 in San Antonio, and exhibits at Booth 506. Its program centres on mRNA medicines carried in lipid nanoparticles, laying out a roadmap for combined studies of their pharmacology, tolerability and immune response.

OrganizationACT 2026 Attendance
Envol Biomedical
New York, NY
◆Gold Supporter
envolbio.com
Contract research organizations (CROs)Gold Supporter
US CRO running pharmacokinetic, pharmacodynamic and investigative toxicology studies in nonhuman primates, with ready access to a large NHP population.
Booth
Exhibiting at Booth 506
Mon, Nov 169:30am–6:30pmTue, Nov 178:00am–4:30pm
Talk
Tue Nov 17
12:00pm–12:55pm

Explore the full ACT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Antonio. Leave your work email and we’ll be in touch.

Privacy

Download the full ACT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Envol Biomedical

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American College of Toxicology (ACT). Organization details are derived from ACT’s published program, exhibitor floor plan and supporter list, and each organization’s own website. Submit a correction